| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| TP2110 | TAT-Gap19 | ||
| Cx43 hemichannel blocker (IC50 ~7 μM). No significant affinity for gap junctions or Panx1 channels. N-terminal transactivator of transcription (TAT) motif promotes membrane permeability and increases inhibitory effect of Gap19. Active in vivo. Brain penet | |||
| TP2110L | TAT-Gap19 acetate | Gap Junction Protein | Cytoskeletal Signaling |
| TAT-Gap19 acetate 是 connexin43 hemichannel (Cx43 HC) 的特异性抑制剂。 它穿过血脑屏障并减轻小鼠的肝纤维化。它不抑制相应的 Cx43 GJC。 | |||
| T41204 |
TAT-Gap19(I130A)
TAT-Gap19(I130A) |
||
| TAT-Gap19(I130A) is a control peptide for TAT-Gap19, a Cx43 hemichannel blocker. TAT-Gap19(I130A) consists of TAT-GAP19 with a I130A amino acid residue change at a key residue for GAP19 activity. In C6 glioma cells expression Cx43, TAT-GAP19(1130A) does not inhibit [Ca2+]i-triggered ATP release at 200 μM. TAT-Gap19(I130A) is cell permeable. | |||
| T75821 | TAT-Gap19 TFA | ||
| TAT-Gap19 TFA 是一种 Cx 模拟肽，是一种特定的 connexin43 半通道 (Cx43 HC) 抑制剂。TAT-Gap19 TFA 不抑制相应的 Cx43 GJC。TAT-Gap19 TFA 可以透过血脑屏障，减轻小鼠的肝纤维化。 | |||
沪公网安备 31010602006700号
